US Oncology Network

Connect with us:

Latest from US Oncology Network


Blue Ridge Cancer Care’s Goldschmidt Presents Data on Managing Hematological Events

January 09, 2022

Studies have shown that administering trilaciclib prior to chemotherapy can reduce myelosuppression and improve health-related quality of life. Jerome Goldschmidt, MD, said future studies will look at how it interacts with immunotherapy.

Community Oncology Leaders Find Silver Linings in the Pandemic

December 20, 2021

Debra Patt, MD, PhD, MBA, of Texas Oncology, and Lucio Gordan, MD, of Florida Cancer Specialists, MD, presented data from a study they conducted in partnership with the Community Oncology Alliance and Avalere Health.

Panel Discusses the Ongoing Evolution of Remote Patient Care

December 19, 2021

The discussion, "Remote Patient Monitoring: Case Studies From the Front Lines,” explored real-world experiences with technology that has taken on greater heft as the COVID-19 pandemic continues to affect health care delivery.

US Oncology Network, Tennessee Oncology Tout Medicare OCM Savings

November 20, 2021

A report from the Centers for Medicare and Medicaid Innovation confirmed that practices within the US Oncology Network and Tennessee Oncology participating in the Oncology Care Model (OCM) program have contributed significant savings to the agency.

Dr Marcus Neubauer Outlines the Benefits of the OCM and the Potential Successor Model

October 01, 2021

The Oncology Care Model (OCM) was a great program that led to practice transformation and improved patient care, but there needs to be a way to address the high cost of cancer therapies, said Marcus Neubauer, MD, chief medical officer of the US Oncology Network.

In Oncology Clinical Pathways, the Variability Isn’t With the Drugs

September 25, 2021

Experts who took part in Patient-Centered Oncology Care® 2021 said when guidelines recommend high-cost targeted therapies or immunotherapies, the focus must turn to areas such as imaging, diagnostic tests, and other elements that contribute to the cost of care.

What's Next After OCM? Possibly a Gap and Something Mandatory, Experts Predict

September 25, 2021

With the Oncology Care Model (OCM) slated to end in 2022, the successor model is still not in place. According to panelists, there is likely going to be a gap after OCM ends and the new model begins, but more importantly, practices should prepare for the new model to be mandatory.

Oncology Value Coalition: Disparities in Cancer Care—Sources and Solutions, Part 3

April 22, 2021

In the inaugural Oncology Value Coalition from The American Journal of Managed Care®, Kashyap Patel, MD, led a discussion with Debra Patt, MD, PhD, MBA; and Karen Winkfield, MD, PhD, exploring findings that suggest minority groups develop cancer at higher rates and experience worse outcomes than nonminority groups.